BOULDER, Colo.--(BUSINESS WIRE)--Covidien (NYSE: COV, BSX: COV), a leading global healthcare products company, today announced the latest advance in its “Unite to Treat Sleep Apnea” initiative, an integrated program connecting physicians, sleep labs, treatment providers and patients to improve the diagnosis and treatment of those afflicted with obstructive sleep apnea. The Company is now partnering with Sleep Pointe, an organization dedicated to providing sleep apnea management and wellness programs within the transportation industry.
